EWASdb: epigenome-wide association study database

       EWASdb : epigenome-wide association study database


EWAS for single marker      EWAS for KEGG Pathway      EWAS for GO Category      Browers by class      Browers by alph      FAQ

The data is big,please wait a moment......

Search Result for GO Categories

Total 1094 records 51/110 page first << upPage  5152535455 downPage >> last

EWAS ID GO ID Class Disease/Phenotype
[sample size n]		 Sample groups
(case/control, trait, cell type etc.)		 Categories GO Term Name GO Term Gene Number Gene Number Annotated In The GO Term Pvalue
Group1
[sample size n]		 Group2
[sample size n]
EWAS1296 GO:0016529 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 cellular_component sarcoplasmic reticulum 36 32 0.000922
EWAS1296 GO:0016740 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function transferase activity 1627 1256 0.000000
EWAS1296 GO:0016772 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function transferase activity, transferring phosphorus-containing groups 846 677 0.000000
EWAS1296 GO:0016773 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function phosphotransferase activity, alcohol group as acceptor 682 561 0.000000
EWAS1296 GO:0016787 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function hydrolase activity 2200 1676 0.000000
EWAS1296 GO:0016788 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function hydrolase activity, acting on ester bonds 668 504 0.000014
EWAS1296 GO:0016791 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function phosphatase activity 236 182 0.000983
EWAS1296 GO:0016817 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function hydrolase activity, acting on acid anhydrides 728 540 0.000166
EWAS1296 GO:0016818 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 725 537 0.000219
EWAS1296 GO:0016820 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances 101 86 0.000029

Total 1094 records 51/110 page first << upPage  5152535455 downPage >> last